CDIVX
Price
$13.92
Change
-$0.06 (-0.43%)
Updated
Sep 20 closing price
VIMSX
Price
$71.38
Change
-$0.13 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

CDIVX vs VIMSX

Header iconCDIVX vs VIMSX Comparison
Open Charts CDIVX vs VIMSXBanner chart's image
Copeland Dividend Growth Fund
Price$13.92
Change-$0.06 (-0.43%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Investor
Price$71.38
Change-$0.13 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CDIVX vs VIMSX Comparison Chart
Loading...
VS
CDIVX vs. VIMSX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDIVX is a Buy and VIMSX is a Buy.

FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 172B vs. CDIVX (40.2M). VIMSX pays higher dividends than CDIVX: VIMSX (1.38) vs CDIVX (0.35). CDIVX was incepted earlier than VIMSX: CDIVX (12 years) vs VIMSX (26 years). CDIVX is a more actively managed with annual turnover of: 35.00 vs. VIMSX (13.00). VIMSX has a lower initial minimum investment than CDIVX: VIMSX (3000) vs CDIVX (25000). VIMSX annual gain was more profitable for investors over the last year : 25.11 vs. CDIVX (19.23). VIMSX return over 5 years is better than : 56.75 vs. CDIVX (3.41).
CDIVXVIMSXCDIVX / VIMSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years26 years-
Gain YTD11.71712.55793%
Front LoadN/AN/A-
Min. Initial Investment250003000833%
Min. Initial Investment IRAN/AN/A-
Net Assets40.2M172B0%
Annual Yield % from dividends0.351.3825%
Returns for 1 year19.2325.1177%
Returns for 3 years1.309.8213%
Returns for 5 years3.4156.756%
Returns for 10 years-1.86128.21-1%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INSE10.090.15
+1.51%
Inspired Entertainment
FOUR86.901.01
+1.18%
Shift4 Payments
CALT40.00-0.16
-0.40%
Calliditas Therapeutics AB
BCE35.04-0.15
-0.43%
BCE
ACST2.70-0.08
-2.88%
Acasti Pharma